Imagine a smart robotic assistant that helps critically ill patients get out of bed and move much sooner than they normally could. Usually, this is a dangerous and exhausting job for nurses to do by hand, so most patients miss out. This system takes over the heavy lifting and uses AI to make the process safe and efficient for everyone.
Only 25% of ICU patients receive early mobilization due to a lack of staff and the physical danger of manual lifting. This leads to slower recovery times and inefficient use of expensive ICU beds.
A 2nd generation AI-driven robotic assistance system including a one-size-fits-all Leg Adapter, a new embedded control system, a specialized hospital bed platform, and a time-optimized user interface.
If you are a hospital group dealing with ICU bed shortages and high recovery times — this project developed an AI-driven robotic system that increases ICU capacity by 27% and accelerates recovery by 20%.
If you are a bed manufacturer dealing with a lack of integrated rehabilitation tools — this project developed a hospital bed platform that optimizes the interaction between the bed and the robot to meet high market demand.
If you are an insurer dealing with the high costs of prolonged ICU stays — this project developed a system that reduces treatment costs by accelerating patient recovery by 20%.
Based on available project data, the system reduces treatment costs by accelerating patient recovery by 20%.
The project focused on reducing Costs of Goods sold (CoGs) and developing a 2nd generation system to facilitate scale-up, including the market introduction of a one-size-fits-all Leg Adapter.
Based on available project data, the technology is developed by Reactive Robotics GmbH, but specific licensing terms are not provided.
It increases ICU capacity by 27% and uses a revised graphical user interface to facilitate time-optimized workflows.
The project period ended in 2024-12-31, with clinical trials already initiated in two German hospitals focusing on pulmonological and neurological patient populations.
The project is led by a single SME, Reactive Robotics GmbH from Germany. With a 100% industry ratio, the project is heavily driven by commercial viability and product development rather than academic research, focusing on reducing manufacturing costs and scaling for a €5bn market.
Contact Reactive Robotics GmbH in Germany for partnership or licensing inquiries.
Contact SciTransfer to explore integration of AI-robotics in your healthcare facility.
